Orchard Therapeutics PLC reports results for the quarter ended in March - Earnings Summary

Orchard Therapeutics

13/05/2021 17:30

* Orchard Therapeutics PLC  ORTX.OQ  reported a quarterly
adjusted loss of 31 cents​​ per share for the quarter ended
in March. The mean expectation of ten analysts for the quarter
was for a loss of 33 cents per share.
* Reported revenue was zero​;  analysts expected $470.63
thousand. 
* Orchard Therapeutics PLC's reported EPS for the quarter was a
loss of 31 cents​.
* The mean earnings estimate of analysts had risen by about 6.1%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Orchard Therapeutics PLC shares had fallen by 24.2% this
quarter and gained 27.3% so far this year.
* The company reported a quarterly loss of $35.18 million.
* Wall Street's median 12-month price target for Orchard
Therapeutics PLC is $15.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 13 at 04:30 p.m. GMT.
​All figures in US dollars